Per ulteriori informazioni selezionare i riferimenti di interesse.
Pharmacoeconomics of clozapine, risperidone and olanzapine - A review of the literature
CNS DRUGS
Olanzapine - A pharmacoeconomic review of its use in schizophrenia
PHARMACOECONOMICS
What about the patient?
JOURNAL OF CLINICAL PSYCHIATRY
Switching from therapy with typical antipsychotic agents to risperidone: Long-term impact on patient outcome
CLINICAL THERAPEUTICS
The current status of tardive dystonia
BIOLOGICAL PSYCHIATRY
RISPERIDONE - A PHARMACOECONOMIC REVIEW OF ITS USE IN SCHIZOPHRENIA
PharmacoEconomics
TREATMENT OF SCHIZOPHRENIA - LETS TALK DOLLARS AND SENSE
American journal of managed care
DEVELOPMENTAL TRAJECTORY AND DISEASE PROGRESSION IN SCHIZOPHRENIA - THE CONUNDRUM, AND INSIGHTS FROM A 12-YEAR PROSPECTIVE-STUDY IN THE MONAGHAN-101
Schizophrenia research
MEASUREMENT OF THE VALIDITY OF UTILITY ELICITATIONS PERFORMED BY COMPUTERIZED INTERVIEW
Medical care